Market Update (NYSE:BAX): Baxter’s BioScience Business Acquires Biopharmaceutical Company SuppreMol

[Business Wire] – Baxter International Inc. and SuppreMol GmbH today announced that Baxter has acquired SuppreMol for EUR 200 million before working capital and other adjustments. Read more on this. Baxter International . . . → Read More: Market Update (NYSE:BAX): Baxter’s BioScience Business Acquires Biopharmaceutical Company SuppreMol Similar Articles: Company Update (NYSE:BAX): Baxter Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters Market Update: Baxter International Inc (NYSE:BAX) – Baxter Declares Quarterly Dividend Company Update (NYSE:BAX): Baxter to Present at the Stifel 2014 Healthcare Conference